Richard Pzena Gilead Sciences, Inc. Transaction History
Pzena Investment Management LLC
- $28.4 Billion
- Q4 2024
A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pzena Investment Management LLC holds 3,223 shares of GILD stock, worth $359,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,223
Previous 2,624
22.83%
Holding current value
$359,171
Previous $219,000
35.62%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.99 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.73 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.46 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...